Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Testicular Neoplasms 1 Testicular Germ Cell Tumor 1 Seminoma 1 Ovarian Neoplasms 1 Multiple Myeloma 1 Lymphoma, Large B-Cell, Diffuse 1 Endodermal Sinus Tumor 1 Central Nervous System Neoplasms 1

Interventions

Rituximab 57 Cyclophosphamide 40 Vincristine 26 Prednisone 25 Doxorubicin 22 Cytarabine 18 Lenalidomide 17 Etoposide 17 Gemcitabine 12 Melphalan 8 Filgrastim 8 Cisplatin 8 zanubrutinib 7 Peripheral Blood Stem Cell Transplantation 7 Oxaliplatin 7 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 7 Methotrexate 7 Ifosfamide 7 Carmustine 7 R-CHOP protocol 6 fludarabine phosphate 5 Vindesine 5 Radiotherapy 5 Dexamethasone 5 Decitabine 5 Busulfan 5 ibrutinib 4 Methylprednisolone 4 Epirubicin 4 Cyclosporine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lymphoma, Large B-Cell, Diffuse × Lenograstim × Clear all

NCT00499018 2011-02-15

DLCL04

Fondazione Italiana Linfomi - ETS

Phase 3 Unknown

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡